Radiation retreatment for very central chest tumors
Part of Cancer clinical trials.
This trial tests a focused form of radiation (SBRT) to treat tumors in the very center of the chest that have already been treated with radiation before. It aims to check safety and whether the tumor can be controlled without causing unacceptable side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a proven (pathology-confirmed) cancer diagnosis.
- Your tumor is in the “ultra-central” area of the chest (very close to major airways/structures).
- You’ve had radiation to that area before, and the tumor is 5 cm or smaller.
- You do not have widespread uncontrolled metastases; if metastases are present, they must be controlled by prior treatment.
- Your general health is good enough for treatment (KPS over 70) and you have no serious or uncontrolled medical problems.
- You can do the radiation sessions—able to lie flat and follow instructions; expected survival is at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how safe and effective a type of focused radiation called SBRT is for cancer tumors in certain chest locations. It’s meant for people whose tumor is small (up to 5 cm) and who don’t have widespread, uncontrolled spread.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
This trial tests a single very high dose of precisely targeted radiation to treat early-stage lung cancer. It aims to destroy the tumor with one treatment session, which may be more convenient and effective than standard radiation.
This trial tests a precise type of radiation therapy for cancer that has spread to the spine. The goal is to see if this treatment is safe and effective in reducing the tumor while protecting your spinal cord and improving your quality of life.
This trial studies a focused, high-dose radiation treatment called SBRT for lung tumors that are hard to operate on, including very central tumors near major airways or organs. It may help people control tumor growth while limiting radiation exposure to nearby critical structures.
This trial studies giving a second course of radiation to tumors in the chest that have come back or not gone away after previous radiation. The goal is to see if a higher dose can be given safely and effectively, while limiting damage to nearby organs.
Hear when a new Thoracic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.